Boston Scientific Corp. closed 9.34% short of its 52-week high of $107.17, which the company reached on February 5th.

The stock's fall snapped a two-day winning streak.

Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular ultrasound system developer SoniVie.

Boston Scientific (BSX) announced it has entered into a definitive agreement to acquire SoniVie, a privately held medical device company that ...

Boston Scientific has gained a duo of CE markings in the European Union (EU) for its navigation enabled Farawave NAV Ablation Catheter for paroxysmal atrial fibrillation (AF) treatment and its new ...

(RTTNews) - Boston Scientific Corp. (BSX), Monday announced its decision to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS Intravascular Ultrasound System.

Boston Scientific, Ireland’s leading medical device employer, has made significant investments in its Irish sites over the past 30 years. Boston Scientific is one of the world leaders in medical ...

Boston Scientific’s BSX fourth-quarter 2024 performance was driven by its robust expansion of operations across different geographies outside the United States. The company’s impressive strategic ...

Boston Scientific has reached an agreement to acquire SoniVie, a medical device company developing the TIVUS Intravascular Ultrasound System, an investigational technology aimed at treating ...

The Food and Drug Administration issued a notice on Friday classifying its recall of the Boston Scientific Accolade pacemaker devices as the most serious type of recall. To date, 832 injuries and ...

Boston Scientific BSX has witnessed strong momentum in the past year. Shares of the company have risen 42.4% compared with 8.5% growth of the industry during the same time frame. The S&P 500 Composite ...

Today's Research Daily features new research reports on 16 major stocks, including The Goldman Sachs Group, Inc. (GS), The Progressive Corp. (PGR) and Boston Scientific Corp. (BSX), as well as ...